<--- Back to Details
First PageDocument Content
Hepatitis / Non-alcoholic fatty liver disease / Steatohepatitis / Fatty liver / Metformin / Cirrhosis / Insulin resistance / Chronic liver disease / Liver biopsy / Medicine / Health / Hepatology
Date: 2014-05-29 13:51:55
Hepatitis
Non-alcoholic fatty liver disease
Steatohepatitis
Fatty liver
Metformin
Cirrhosis
Insulin resistance
Chronic liver disease
Liver biopsy
Medicine
Health
Hepatology

Microsoft PowerPoint - Kohli - NASH.pptx

Add to Reading List

Source URL: www.naspghan.org

Download Document from Source Website

File Size: 718,31 KB

Share Document on Facebook

Similar Documents

Obeticholic Acid for the Treatment of Nonalcoholic Steatohepatitis: Comparative Clinical Effectiveness and Value Draft Evidence Report May 25, 2016 Institute for Clinical and Economic Review

DocID: 1nwXZ - View Document

Alcohol / Hepatitis / Nutrition / Hepatology / Alcoholism / Alcoholic beverage / Steatohepatitis / Disease theory of alcoholism / Cirrhosis / Medicine / Alcohol abuse / Health

doi:j.jhep

DocID: 1fsCV - View Document

Hepatitis / HIV/AIDS / Virology / Hepatology / Hepatitis C / Steatohepatitis / Hepatocellular carcinoma / Medicaid / Coinfection / Medicine / Health / Biology

New York PREPARED BY THE CENTER FOR HEALTH LAW AND POLICY INNOVATION OF HARVARD LAW SCHOOL New York

DocID: 1aoGf - View Document

Biology / Hepatitis C / Steatohepatitis / Hepatocellular carcinoma / Hepacivac / Hepatitis C and HIV co-infection / Medicine / Hepatitis / Health

Final report 2008 Review of Hepatitis C

DocID: 188J8 - View Document

Hepatitis / Hepatology / Histopathology / Non-alcoholic fatty liver disease / Alcohol abuse / Steatohepatitis / Fatty liver / Cirrhosis / Steatosis / Medicine / Health / Anatomy

NASH associated with a 50 percent higher chance of death compared with NAFLD

DocID: 17AQx - View Document